Drug shortage
Levothyroxine Sodium Tablet · EMD Serono, Inc.
FDA drug shortage · To Be Discontinued · updated Jul 10, 2025
Key facts
| Generic name | Levothyroxine Sodium Tablet |
|---|---|
| Company | EMD Serono, Inc. |
| Presentation | Euthyrox, Tablet, 112 ug (NDC 72305-112-90) |
| Dosage form | Tablet |
| Status | To Be Discontinued |
| Therapeutic category | Endocrinology/Metabolism |
| Package NDCs | 72305-112-90 |
| First posted | Jul 10, 2025 |
| Last updated | Jul 10, 2025 |
| Discontinued | Jul 10, 2025 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: